查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576776

半乳糖血症市場：按類型、診斷、治療方法、年齡層、最終用戶、產品、測試、分析 - 2025-2030 年全球預測

Galactosemia Market by Type, Diagnosis Methods, Treatment Approaches, Age Group, End Users, Products, Tests And Assays - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年半乳糖血症市值為5.0425億美元，預計到2024年將達到5.3154億美元，複合年成長率為6.86%，到2030年將達到8.0253億美元。

半乳糖血症是一種罕見的遺傳性疾病，會影響人體處理和代謝半乳糖的能力，半乳糖是存在於牛奶和其他乳製品中的碳水化合物。此疾病的範圍主要包括新生兒篩檢、早期診斷和飲食管理，以預防認知障礙和肝損傷等嚴重併發症。由於迫切需要有效的診斷工具和治療方法，因此該領域的市場研究需求非常大。這些開發成果的應用範圍已擴展到醫療保健專業人員、醫院、新生兒篩檢計畫和專業製藥公司。一系列最終用途包括兒科醫療中心、遺傳研究實驗室和專注於遺傳代謝疾病的營養服務。

主要市場統計
基準年[2023] 5.0425億美元
預測年份 [2024] 53154萬美元
預測年份 [2030] 80253萬美元
複合年成長率（%） 6.86%

根據市場洞察，半乳糖血症領域的成長受到人們對遺傳疾病認知的提高、遺傳篩檢技術的進步以及對罕見疾病研究的投資增加的顯著影響。最新的商機在於創新營養食品、酵素替代療法和個人化醫療方法的開發。利用這些機會的研究包括與研究機構建立策略夥伴關係以及投資先進的基因檢測技術。然而，由於疾病罕見、研發成本高以及孤兒藥法律規範等因素，市場成長受到限制。也存在一些挑戰，例如某些地區的認知度較低以及專業醫療設施的可用性較低。

需要創新和研究的領域包括開發非侵入性篩檢方法、探索基因治療解決方案以及加強飲食管理通訊協定。公司還可以專注於制定教育計劃，以促進早期發現和有效的管理策略。對市場性質的深入了解表明，由於對罕見疾病的宣傳和政府支持的增加，這是一個利基市場，但正在穩步擴大。鼓勵在這一領域營運的公司投資尖端研究，並與患者倡導組織合作，擴大市場範圍並開發以患者為中心的解決方案。

市場動態：快速發展的半乳糖血症市場的關鍵市場洞察

供需的動態交互作用正在改變半乳糖血症市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大學術機構和生物技術公司在研究和藥物開發方面的合作
    • 解決代謝紊亂的酵素替代療法的開發和商業化
    • 增加患者倡導和支持團體推動研究和政策變革
    • 透過個人化醫療和標靶治療方法的進步提供臨床益處
  • 市場限制因素
    • 半乳糖血症的低盛行率限制了治療的可能性
  • 市場機會
    • 擴大新生兒半乳糖血症的治療選擇並改善早期檢測方法
    • 開發先進的診斷工具和標靶治療，以解決成年半乳糖血症患者的特定酵素缺乏症
    • 為半乳糖血症患者提供遺傳諮詢和家庭支持服務的創新方法
  • 市場挑戰
    • 由於缺乏對半乳糖血症的認知和及時診斷而延誤治療

波特的五力：駕馭半乳糖血症市場的策略工具

波特的五力架構是了解半乳糖血症市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解半乳糖血症市場的外部影響

外在宏觀環境因素在塑造半乳糖血症市場的表現動態中發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解半乳糖血症市場的競爭格局

對半乳糖血症市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣半乳糖血症市場供應商績效評估

FPNV 定位矩陣是評估半乳糖血症市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製半乳糖血症市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，半乳糖血症市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大學術機構與生物技術公司在研究和藥物開發方面的合作
      • 解決代謝紊亂的酵素替代療法的開發和商業化
      • 越來越多的患者倡導和支持團體推動研究和政策變革
      • 個人化醫療和標靶治療方法的進步將帶來臨床益處
    • 抑制因素
      • 半乳糖血症的低盛行率限制了治療和治療的可能性
    • 機會
      • 擴大新生兒半乳糖血症的治療選擇並改善早期檢測方法
      • 開發先進的診斷工具和標靶治療治療，以解決成人半乳糖血症患者的特定酵素缺乏問題
      • 為半乳糖血症患者提供遺傳諮詢和家庭支持服務的創新方法
    • 任務
      • 對半乳糖血症缺乏認知和及時診斷導致治療延誤
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章半乳糖血症市場：依類型

  • 經典半乳糖血症
    • 強風缺乏症
    • GALK缺乏症
    • GALT缺乏症
  • 臨床變異
  • 杜阿爾特變種

第7章依診斷方法分類的半乳糖血症市場

  • 酵素測定
  • 基因檢測
  • 新生兒篩檢測試
    • 足跟採血試驗
    • 質譜分析

第8章半乳糖血症市場（依治療方法）

  • 膳食管理
    • 補充品
    • 半乳糖限制飲食
    • 大豆配方奶粉
  • 酵素替代療法
  • 基因治療

第9章半乳糖血症市場：依年齡層

  • 成人
  • 孩子們
  • 嬰兒
  • 新生

第 10 章 半乳糖血症市場：依最終使用者分類

  • 學術機構
  • 診斷實驗室
    • 臨床實驗室
    • 研究室
  • 醫院
    • 私立醫院
    • 公立醫院

第11章半乳糖市場：依產品

  • 數學公式
    • 不含乳糖
    • 大豆配方奶粉
  • 藥品
  • 補充品
    • 補充品
    • 維生素補充品

第 12 章。

  • 確認測試
    • 脫氧核糖核酸測試
    • 酵素測定
  • 後續測試
  • 篩檢測試

第13章美洲半乳糖市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太半乳糖血症市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章歐洲、中東和非洲半乳糖市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C629188A1

The Galactosemia Market was valued at USD 504.25 million in 2023, expected to reach USD 531.54 million in 2024, and is projected to grow at a CAGR of 6.86%, to USD 802.53 million by 2030.

Galactosemia is a rare genetic disorder affecting the body's ability to process and metabolize galactose, a sugar found in milk and other dairy products. The scope of this condition primarily involves newborn screening, early diagnosis, and dietary management to prevent severe complications such as cognitive impairment and liver damage. The necessity for market research in this area is pronounced due to the critical need for effective diagnostic tools and treatments. The application of these developments extends to healthcare professionals, hospitals, newborn screening programs, and specialty pharmaceutical companies. End-use scope includes pediatric care centers, genetic research institutions, and dietetic services focused on inherited metabolic disorders.

KEY MARKET STATISTICS
Base Year [2023] USD 504.25 million
Estimated Year [2024] USD 531.54 million
Forecast Year [2030] USD 802.53 million
CAGR (%) 6.86%

Market insights indicate that growth in the galactosemia space is significantly influenced by rising awareness of genetic disorders, advancements in genetic screening technologies, and increasing investment in rare disease research. The latest opportunities lie in the development of innovative dietary supplements, enzyme replacement therapies, and personalized medicine approaches. Recommendations for leveraging these opportunities include forming strategic partnerships with research institutions and investing in advanced genetic testing technologies. However, limitations in market growth stem from factors such as the rarity of the condition, high research and development costs, and stringent regulatory frameworks for orphan drugs. The challenging factors also include the lack of awareness in certain regions and limited availability of specialized healthcare facilities.

Areas ripe for innovation and research include the development of non-invasive screening methods, exploring gene therapy solutions, and enhancing dietary management protocols. Businesses could also focus on creating educational programs to promote early detection and effective management strategies. Insight into the nature of the market reveals it to be niche but steadily expanding due to increased advocacy and government support for rare diseases. Companies operating in this space are advised to invest in cutting-edge research and collaborate with patient advocacy groups to expand market reach and develop patient-centric solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Galactosemia Market

The Galactosemia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing collaborations between academic institutions and biotech firms for research and drug development
    • Development and commercialization of enzyme replacement therapies to address metabolic disorders
    • Increasing patient advocacy and support groups driving research and policy changes
    • Advancements in personalized medicine and targeted treatment approaches, offering clinical benefits
  • Market Restraints
    • Low prevalence of galactosemia limiting the potential for treatments and therapies
  • Market Opportunities
    • Expanding treatment options and improving early detection methods for galactosemia in neonates
    • Developing advanced diagnostic tools and targeted therapies to address specific enzyme deficiencies in adult patients with galactosemia
    • Innovative approaches to genetic counseling and family support services for those impacted by galactosemia
  • Market Challenges
    • Lack of awareness and timely diagnosis of galactosemia leading to delayed treatment

Porter's Five Forces: A Strategic Tool for Navigating the Galactosemia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Galactosemia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Galactosemia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Galactosemia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Galactosemia Market

A detailed market share analysis in the Galactosemia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Galactosemia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Galactosemia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Galactosemia Market

A strategic analysis of the Galactosemia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Galactosemia Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, Audentes Therapeutics, BioMarin Pharmaceutical Inc., BridgeBio Pharma, Erytech Pharma, GlaxoSmithKline, Hospira, Johnson & Johnson, LogicBio Therapeutics, Moderna, Novartis, Orphalan, Pfizer, Roche, Sanofi, Sarepta Therapeutics, Ultragenyx Pharmaceutical Inc., uniQure, and Vertex Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Galactosemia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Classic Galactosemia, Clinical Variant, and Duarte Variant. The Classic Galactosemia is further studied across GALE Deficiency, GALK Deficiency, and GALT Deficiency.
  • Based on Diagnosis Methods, market is studied across Enzyme Assay, Genetic Testing, and Newborn Screening Tests. The Newborn Screening Tests is further studied across Heel Prick Test and Mass Spectrometry.
  • Based on Treatment Approaches, market is studied across Dietary Management, Enzyme Replacement Therapy, and Gene Therapy. The Dietary Management is further studied across Calcium Supplements, Galactose-Restricted Diet, and Soy-Based Formula.
  • Based on Age Group, market is studied across Adults, Children, Infants, and Newborns.
  • Based on End Users, market is studied across Academic Institutions, Diagnostic Laboratories, and Hospitals. The Diagnostic Laboratories is further studied across Clinical Laboratories and Research Laboratories. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Products, market is studied across Formulas, Pharmaceuticals, and Supplements. The Formulas is further studied across Lactose-Free Formula and Soy-Based Formula. The Supplements is further studied across Calcium Supplements and Vitamin Supplements.
  • Based on Tests And Assays, market is studied across Confirmatory Tests, Follow-Up Tests, and Screening Tests. The Confirmatory Tests is further studied across DNA Testing and Enzyme Assays.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing collaborations between academic institutions and biotech firms for research and drug development
      • 5.1.1.2. Development and commercialization of enzyme replacement therapies to address metabolic disorders
      • 5.1.1.3. Increasing patient advocacy and support groups driving research and policy changes
      • 5.1.1.4. Advancements in personalized medicine and targeted treatment approaches, offering clinical benefits
    • 5.1.2. Restraints
      • 5.1.2.1. Low prevalence of galactosemia limiting the potential for treatments and therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding treatment options and improving early detection methods for galactosemia in neonates
      • 5.1.3.2. Developing advanced diagnostic tools and targeted therapies to address specific enzyme deficiencies in adult patients with galactosemia
      • 5.1.3.3. Innovative approaches to genetic counseling and family support services for those impacted by galactosemia
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and timely diagnosis of galactosemia leading to delayed treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Galactosemia Market, by Type

  • 6.1. Introduction
  • 6.2. Classic Galactosemia
    • 6.2.1. GALE Deficiency
    • 6.2.2. GALK Deficiency
    • 6.2.3. GALT Deficiency
  • 6.3. Clinical Variant
  • 6.4. Duarte Variant

7. Galactosemia Market, by Diagnosis Methods

  • 7.1. Introduction
  • 7.2. Enzyme Assay
  • 7.3. Genetic Testing
  • 7.4. Newborn Screening Tests
    • 7.4.1. Heel Prick Test
    • 7.4.2. Mass Spectrometry

8. Galactosemia Market, by Treatment Approaches

  • 8.1. Introduction
  • 8.2. Dietary Management
    • 8.2.1. Calcium Supplements
    • 8.2.2. Galactose-Restricted Diet
    • 8.2.3. Soy-Based Formula
  • 8.3. Enzyme Replacement Therapy
  • 8.4. Gene Therapy

9. Galactosemia Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adults
  • 9.3. Children
  • 9.4. Infants
  • 9.5. Newborns

10. Galactosemia Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic Institutions
  • 10.3. Diagnostic Laboratories
    • 10.3.1. Clinical Laboratories
    • 10.3.2. Research Laboratories
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals

11. Galactosemia Market, by Products

  • 11.1. Introduction
  • 11.2. Formulas
    • 11.2.1. Lactose-Free Formula
    • 11.2.2. Soy-Based Formula
  • 11.3. Pharmaceuticals
  • 11.4. Supplements
    • 11.4.1. Calcium Supplements
    • 11.4.2. Vitamin Supplements

12. Galactosemia Market, by Tests And Assays

  • 12.1. Introduction
  • 12.2. Confirmatory Tests
    • 12.2.1. DNA Testing
    • 12.2.2. Enzyme Assays
  • 12.3. Follow-Up Tests
  • 12.4. Screening Tests

13. Americas Galactosemia Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Galactosemia Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Galactosemia Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie
  • 2. Amgen
  • 3. Audentes Therapeutics
  • 4. BioMarin Pharmaceutical Inc.
  • 5. BridgeBio Pharma
  • 6. Erytech Pharma
  • 7. GlaxoSmithKline
  • 8. Hospira
  • 9. Johnson & Johnson
  • 10. LogicBio Therapeutics
  • 11. Moderna
  • 12. Novartis
  • 13. Orphalan
  • 14. Pfizer
  • 15. Roche
  • 16. Sanofi
  • 17. Sarepta Therapeutics
  • 18. Ultragenyx Pharmaceutical Inc.
  • 19. uniQure
  • 20. Vertex Pharmaceuticals

LIST OF FIGURES

  • FIGURE 1. GALACTOSEMIA MARKET RESEARCH PROCESS
  • FIGURE 2. GALACTOSEMIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GALACTOSEMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GALACTOSEMIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GALACTOSEMIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. GALACTOSEMIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. GALACTOSEMIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GALACTOSEMIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GALACTOSEMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GALACTOSEMIA MARKET DYNAMICS
  • TABLE 7. GLOBAL GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALK DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALT DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLINICAL VARIANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GALACTOSEMIA MARKET SIZE, BY DUARTE VARIANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GALACTOSEMIA MARKET SIZE, BY HEEL PRICK TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GALACTOSEMIA MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GALACTOSEMIA MARKET SIZE, BY CALCIUM SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALACTOSE-RESTRICTED DIET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GALACTOSEMIA MARKET SIZE, BY SOY-BASED FORMULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GALACTOSEMIA MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GALACTOSEMIA MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GALACTOSEMIA MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GALACTOSEMIA MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GALACTOSEMIA MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GALACTOSEMIA MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GALACTOSEMIA MARKET SIZE, BY FORMULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GALACTOSEMIA MARKET SIZE, BY LACTOSE-FREE FORMULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GALACTOSEMIA MARKET SIZE, BY SOY-BASED FORMULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL GALACTOSEMIA MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL GALACTOSEMIA MARKET SIZE, BY CALCIUM SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL GALACTOSEMIA MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL GALACTOSEMIA MARKET SIZE, BY DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL GALACTOSEMIA MARKET SIZE, BY FOLLOW-UP TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL GALACTOSEMIA MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 176. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 178. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 180. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 184. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 187. CHINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 188. CHINA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 189. CHINA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 190. CHINA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 191. CHINA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. CHINA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 193. CHINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 194. CHINA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. INDIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 202. INDIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 203. INDIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 204. INDIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 205. INDIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 206. INDIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 207. INDIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 208. INDIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 209. INDIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 210. INDIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 211. INDIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 212. INDIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. INDIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 214. INDIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 215. INDONESIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. INDONESIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 217. INDONESIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 218. INDONESIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 219. INDONESIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 220. INDONESIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 221. INDONESIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 222. INDONESIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 223. INDONESIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 224. INDONESIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 225. INDONESIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 226. INDONESIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 227. INDONESIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. INDONESIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 229. INDONESIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 230. JAPAN GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. JAPAN GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 232. JAPAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 233. JAPAN GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 234. JAPAN GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 235. JAPAN GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 236. JAPAN GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 237. JAPAN GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 238. JAPAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 239. JAPAN GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 240. JAPAN GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 241. JAPAN GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 242. JAPAN GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 243. JAPAN GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 244. JAPAN GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 245. MALAYSIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. MALAYSIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 247. MALAYSIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 248. MALAYSIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 249. MALAYSIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 250. MALAYSIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 251. MALAYSIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 252. MALAYSIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 253. MALAYSIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 254. MALAYSIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 255. MALAYSIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 256. MALAYSIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 257. MALAYSIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. MALAYSIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 259. MALAYSIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 260. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 262. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 264. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 266. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 268. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 270. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 272. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 274. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 275. SINGAPORE GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SINGAPORE GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 277. SINGAPORE GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 278. SINGAPORE GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 279. SINGAPORE GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 280. SINGAPORE GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 281. SINGAPORE GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 282. SINGAPORE GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 283. SINGAPORE GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 284. SINGAPORE GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 285. SINGAPORE GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. SINGAPORE GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 287. SINGAPORE GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 288. SINGAPORE GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 289. SINGAPORE GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 296. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 298. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 300. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 302. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 304. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 305. TAIWAN GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TAIWAN GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 307. TAIWAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 308. TAIWAN GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 309. TAIWAN GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 310. TAIWAN GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 311. TAIWAN GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 312. TAIWAN GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 313. TAIWAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 314. TAIWAN GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 315. TAIWAN GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 316. TAIWAN GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 317. TAIWAN GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. TAIWAN GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 319. TAIWAN GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 320. THAILAND GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. THAILAND GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 322. THAILAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 323. THAILAND GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 324. THAILAND GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 325. THAILAND GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 326. THAILAND GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 327. THAILAND GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 328. THAILAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 329. THAILAND GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 330. THAILAND GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 331. THAILAND GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 332. THAILAND GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 333. THAILAND GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 334. THAILAND GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 335. VIETNAM GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. VIETNAM GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 337. VIETNAM GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 338. VIETNAM GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 339. VIETNAM GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 340. VIETNAM GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 341. VIETNAM GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 342. VIETNAM GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 343. VIETNAM GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 344. VIETNAM GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 345. VIETNAM GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 346. VIETNAM GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 347. VIETNAM GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 348. VIETNAM GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
  • TABLE 349. VIETNAM GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 355. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 356. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 357. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 358. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 359. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 360. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 361. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
  • TABLE 362. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 363. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 201